NH Nongwoobio Co., Ltd. (KOSDAQ:054050)
South Korea · Delayed Price · Currency is KRW 7,310.00
0.00 (0.00%)
At close: May 21, 2026
NH Nongwoobio Revenue
In the year 2025, NH Nongwoobio had annual revenue of 158.79B KRW with 9.75% growth. NH Nongwoobio had revenue of 39.18B in the quarter ending December 31, 2025, with 24.68% growth.
Revenue
158.79B
Revenue Growth
+9.75%
P/S Ratio
0.74
Revenue / Employee
476.84M
Employees
333
Market Cap
117.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.79B | 14.11B | 9.75% |
| Dec 31, 2024 | 144.68B | 8.84B | 6.50% |
| Dec 31, 2023 | 135.84B | 2.44B | 1.83% |
| Dec 31, 2022 | 133.40B | 557.04M | 0.42% |
| Dec 31, 2021 | 132.84B | 2.81B | 2.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sangsangin | 418.56B |
| CoAsia | 375.13B |
| HANPASS | 66.45B |
| Amicogen | 41.98B |
| Codes Combine | 39.72B |
| YAS Co., Ltd. | 34.76B |
| Dongsin Engineering & Construction | 33.38B |
| Cytogen | 26.05B |
NH Nongwoobio News
- 2 months ago - NH Nongwoobio Annual report: Q4 2025 - Filings
- 2 months ago - NH Nongwoobio Quarterly report: Q4 2025 - Filings
- 6 months ago - NH Nongwoobio Quarterly report: Q3 2025 - Filings
- 10 months ago - NH Nongwoobio Quarterly report: Q2 2025 - Filings